SCHEMBL13026017

SCHEMBL13026017

CCCCCc1ccc(-c2ccc(C(F)(F)Oc3ccc(-c4ccc(C)c(C(F)F)c4F)cc3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 10/20 0.36
HSD11B1 P28845 3/20 0.36
FAAH O00519 1/20 0.33
RARA P10276 2/20 0.33
RARG P13631 1/20 0.33
THRB P10828 1/20 0.33
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 2/20 0.32
ALDH1A1 P00352 2/20 0.32
KMT2A Q03164 2/20 0.32
USP2 O75604 1/20 0.32
LMNA P02545 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
SLCO1B3 Q9NPD5 1/20 0.32
SLCO1B1 Q9Y6L6 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13025931 0.92 S1PR1 (0.32) S1PR1
SCHEMBL13025928 0.92 S1PR1 (0.32) S1PR1
SCHEMBL12834692 0.86 RARB (0.45) RARBHSD11B1RARARARGTSHR
SCHEMBL13026018 0.83 HRH3 (0.43) RARBTSHRHSD17B10MEN1ALDH1A1
SCHEMBL13026012 0.81 ALDH1A1 (0.30) ALDH1A1LMNAMAPT
SCHEMBL12623141 0.80 RARB (0.43) RARBHSD11B1RARARARGMEN1
SCHEMBL13025929 0.79 S1PR1 (0.32) S1PR1S1PR3
SCHEMBL12625667 0.79 RARB (0.43) RARBFAAHRARARARGMEN1
SCHEMBL13025912 0.79 MAOB (0.31)
SCHEMBL12622969 0.78 RARB (0.47) RARBRARARARGTSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838087-B2 Benzene derivative, liquid crystal composition and liquid crystal display device CHISSO CORPORATION (JP) 2010-11-23 US disclosed
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device JNC PETROCHEMICAL CORPORATION (JP) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device CCND2, YBX1, CNKSR1 RARB 228/4885HSD11B1 1363/4885FAAH 2648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.